tiprankstipranks
Advertisement
Advertisement

JP:190A Stock Latest News

Chordia Wins Japan Orphan Drug Status for Lead AML Therapy rogocekib
Company AnnouncementsChordia Wins Japan Orphan Drug Status for Lead AML Therapy rogocekib
4d ago
190A
Chordia’s Lead Cancer Drug Rogocekib Wins Japan Orphan Drug Endorsement for AML
PremiumCompany Announcements
Chordia’s Lead Cancer Drug Rogocekib Wins Japan Orphan Drug Endorsement for AML
1M ago
190A
Chordia Therapeutics Wins AMED Grant for Advanced Cancer Research with Kyoto University
PremiumCompany Announcements
Chordia Therapeutics Wins AMED Grant for Advanced Cancer Research with Kyoto University
1M ago
190A
Chordia Therapeutics Narrows Nine-Month Loss But Stays Deep in Red
PremiumCompany Announcements
Chordia Therapeutics Narrows Nine-Month Loss But Stays Deep in Red
1M ago
190A
Chordia Therapeutics Sets Agenda for Q2 FY 2026 Financial and Pipeline Update
PremiumCompany Announcements
Chordia Therapeutics Sets Agenda for Q2 FY 2026 Financial and Pipeline Update
5M ago
190A
Chordia Therapeutics Narrows Interim Loss but Maintains Full-Year Red-Ink Forecast
PremiumCompany AnnouncementsChordia Therapeutics Narrows Interim Loss but Maintains Full-Year Red-Ink Forecast
5M ago
190A
Chordia Therapeutics Doses First Patient in Rogocekib Expansion Cohort
Premium
Company Announcements
Chordia Therapeutics Doses First Patient in Rogocekib Expansion Cohort
5M ago
190A
Chordia Advances Rogocekib Leukemia Trial With FDA-Aligned Expansion Cohorts
Premium
Company Announcements
Chordia Advances Rogocekib Leukemia Trial With FDA-Aligned Expansion Cohorts
6M ago
190A
Chordia Regains Full Rights to CTX-177 After Ending Ono License Deal
PremiumCompany Announcements
Chordia Regains Full Rights to CTX-177 After Ending Ono License Deal
6M ago
190A
Chordia Therapeutics’ Major Shareholder Diluted Below 10% After Warrant Exercises
PremiumCompany Announcements
Chordia Therapeutics’ Major Shareholder Diluted Below 10% After Warrant Exercises
7M ago
190A
Chordia Therapeutics Narrows Quarterly Loss but Forecasts Continued Full-Year Red Ink
PremiumCompany Announcements
Chordia Therapeutics Narrows Quarterly Loss but Forecasts Continued Full-Year Red Ink
8M ago
190A
Chordia Therapeutics to Record Grant Income in Fiscal Year 2026
PremiumCompany Announcements
Chordia Therapeutics to Record Grant Income in Fiscal Year 2026
9M ago
190A
Chordia Therapeutics’ CTX-712 Study: A Potential Breakthrough in AML and HR-MDS Treatment
PremiumCompany AnnouncementsChordia Therapeutics’ CTX-712 Study: A Potential Breakthrough in AML and HR-MDS Treatment
10M ago
190A
Chordia Therapeutics Restructures Capital to Strengthen Financial Foundation
Premium
Company Announcements
Chordia Therapeutics Restructures Capital to Strengthen Financial Foundation
10M ago
190A
Chordia Therapeutics Reports Fiscal Year 2025 Financial Results
Premium
Company Announcements
Chordia Therapeutics Reports Fiscal Year 2025 Financial Results
11M ago
190A
Chordia Therapeutics Reports Continued Losses in Latest Financial Results
PremiumCompany Announcements
Chordia Therapeutics Reports Continued Losses in Latest Financial Results
1y ago
190A
Chordia Therapeutics Secures Grant for Cancer Therapy Research
PremiumCompany Announcements
Chordia Therapeutics Secures Grant for Cancer Therapy Research
1y ago
190A
Chordia Therapeutics Announces Change in Major Shareholder
PremiumCompany Announcements
Chordia Therapeutics Announces Change in Major Shareholder
1y ago
190A
Chordia Therapeutics Regains Rights to CTX-177 as Ono Discontinues Development
PremiumCompany Announcements
Chordia Therapeutics Regains Rights to CTX-177 as Ono Discontinues Development
1y ago
190A
Chordia Therapeutics Reports Financial Losses for Six-Month Period Ending February 2025
PremiumCompany AnnouncementsChordia Therapeutics Reports Financial Losses for Six-Month Period Ending February 2025
1y ago
190A
Chordia Therapeutics Secures Orphan Drug Designation for Rogocekib in the U.S.
Premium
Company Announcements
Chordia Therapeutics Secures Orphan Drug Designation for Rogocekib in the U.S.
2y ago
190A
Chordia Therapeutics Unveils New Research Insights
Premium
Company Announcements
Chordia Therapeutics Unveils New Research Insights
2y ago
190A

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >